Effects of caffeic acid phenethyl ester on matrix molecules and angiogenetic and anti-angiogenetic factors in gastric cancer cells cultured on different substrates

References

• Abdel-Latif MM, Windle HJ, Homasany BS, Sabra K, Kelleher D (2005)Caffeic acid phenethyl ester modulates Helicobacter pylori-induced nuclear factor-kappa B and activator protein-1 expression in gastric epithelial cells. Br. J. Pharmacol. 146: 1139–1147.
   PubMed Web of Science ®Google Scholar
• Adams JC, Watt FM (1993)Regulation of development and differentiation by the extracellular matrix. Development 117: 1183–1198.
   PubMed Web of Science ®Google Scholar
• Albo D, Shinohara T, Tuszynski GP (2002)Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer. J. Surg. Res. 108: 51–60.
   PubMed Web of Science ®Google Scholar
• Aminin DL, Menchinskaya ES, Pisliagin EA, Silchenko AS, Avilov SA, Kalinin VI (2015)Anticancer activity of sea cucumber triterpene glycosides. Mar. Drugs 6: 1202–1223.
   Web of Science ®Google Scholar
• Ateş U, Uyanikgil Y, Baka M, Ozdaş E, Biçer S, Ergen G (2009)Subacute effect of 2,4-dichlorophenoxyacetic acid on rat liver tissue: histochemical and immunohistochemical study. Anal. Quant. Cytol. Histol. 31: 354–362.
   PubMed Web of Science ®Google Scholar
• Ayrton de Toledo O, Pinto LP, Ruız AP (2010)Immunohistochemical expression of vascular endothelial growth factor and matrix metalloproteinase-9 in radicular and residual radicular cysts. J. Appl. Oral Sci. 18: 613–620.
   PubMed Web of Science ®Google Scholar
• Benton G, Crooke E, George J (2009)Laminin-1 induces E-cadherin expression in 3-dimensional cultured breast cancer cells by inhibiting DNA methyltransferase 1 and reversing promoter methylation status. FASEB J. 23: 3884–3895.
   PubMed Web of Science ®Google Scholar
• Brahimi-Horn MC, Pouysségur J (2007)Hypoxia in cancer cell metabolism and pH regulation. Essays Biochem. 43: 165–178.
   PubMed Web of Science ®Google Scholar
• Cavdar Z, Canda AE, Terzi C, Sarioglu S, Fuzun M, Oktay G (2011)Role of gelatinases (matrix metalloproteinases 2 and 9), vascular endothelial growth factor and endostatin on clinicopathological behaviour of rectal cancer. Colorect. Dis. 13: 154–160.
   PubMed Web of Science ®Google Scholar
• Chan GC, Cheung KW, Sze DM (2013)The immunomodulatory and anticancer properties of propolis. Clin. Rev. Aller. Immunol. 44: 262–273.
   PubMed Web of Science ®Google Scholar
• Chen R, Wang S, Yao Y, Zhou Y, Zhang C, Fang J, Zhang D, Zhang L, Pan J (2015)Anti-metastatic effects of DNA vaccine encoding single-chain trimer composed of MHC I and vascular endothelial growth factor receptor 2 peptide. Oncol. Rep. 33: 2269–2276.
   PubMed Web of Science ®Google Scholar
• Chung TW, Kim SJ, Choi HJ, Kwak CH, Song KH, Suh SJ, Kim KJ, Ha KT, Park YG, Chang YC, Chang HW, Lee YC, Kim CH (2013)CAPE suppresses VEGFR-2 activation, and tumor neovascularization and growth. J. Mol. Med. 91: 271–282.
   PubMed Web of Science ®Google Scholar
• Cox G, O’Byrne KJ (2001)Matrix metalloproteinases and cancer. Anticancer Res. 21: 4207–4219.
   PubMed Web of Science ®Google Scholar
• Cross VL, Zheng Y, Choi NW, Verbridge SS, Sutermaster BA, Bonassar LJ, Fischbach C, Stroock AD (2010)Dense type I collagen matrices that support cellular remodeling and microfabrication for studies of tumor angiogenesis and vasculogenesis in vitro. Biomaterials 3: 8596–8607.
   Web of Science ®Google Scholar
• De Vita F, Giuliani F, Silvestris N, Rossetti S, Pizzolorusso A, Santabarbara G, Galizia G, Colucci G, Ciardiello F, Orditura M (2012)Current status of targeted therapies in advanced gastric cancer. Exp. Opin. Ther. Targ. 16: 29–34.
   PubMed Web of Science ®Google Scholar
• Dönmez G, Sullu Y, Sancar B, Yıldız L, Aydın O, Karagöz F, Barış S, Kandemir B (2009)Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas. Pathol. Res. Prac. 205: 854–857.
   PubMed Web of Science ®Google Scholar
• Feng S, Zhou L, Nice EC, Huang C (2015)Fibroblast growth factor receptors: multifactorial-contributors to tumor initiation and progression. Histol. Histopathol. 30: 13–31.
   PubMed Web of Science ®Google Scholar
• Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaissé J (2000)Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. 486: 247–251.
   PubMed Web of Science ®Google Scholar
• Folkman J (2006)Antiangiogenesis in cancer therapy endostatin and its mechanisms of action. Exp. Cell Res. 312: 594–507.
   PubMed Web of Science ®Google Scholar
• Fontanella C, Ongaro E, Bolzonello S, Guardascione M, Fasola G, Aprile G (2014)Clinical advances in the development of novel VEGFR2 inhibitors. Ann. Transl. Med. 2: 123.
   PubMedGoogle Scholar
• Gaileli C, Theocharis AD, Karamanos NK (2011)Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 278: 16–27.
   PubMed Web of Science ®Google Scholar
• Greenaway J, Lawler J, Moorehead R, Bornstein P, Lamarre J, Petrik J (2007)Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1). J. Cell. Physiol. 210: 807–818.
   PubMed Web of Science ®Google Scholar
• Gungorduk K, Ertas IE, Sahbaz A, Ozvural S, Sarica Y, Ozdemir A, Sayhan S, Gokcu M, Yilmaz B, Sanci M, Inan S, Harma M, Yildirim Y (2014)Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group. Eur. J. Obstet. Gynecol. Reprod. Biol. 179: 147–152.
   PubMed Web of Science ®Google Scholar
• Gupta MK, Qin RY (2003)Mechanism and its regulation of tumor-induced angiogenesis. World J. Gastroentrol. 6: 1144–1155.
   Google Scholar
• Hamil KJ, Kligys K, Hopkinson SB, Jones JCR (2009)Laminin deposition in the extracellular matrix: a complex picture emerges. J. Cell Sci. 122: 4409–4417.
   PubMed Web of Science ®Google Scholar
• Huang SP, Wu MS, Shun CT, Wang HP, Lin MT, Kuo ML, Lin JT (2004)Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. J. Biomed. Sci. 11: 517–527.
   PubMed Web of Science ®Google Scholar
• Iordache S, Saftoiu A, Georgescu CV, Ramboiu S, Gheonea DI, Filip M, Schenker M, Ciurea T (2010)Vascular endothelial growth factor expression and microvessel density-two useful tools for the assessment of prognosis and survival in gastric cancer patients. J. Gastrointes. Liver Dis. 19: 135–139.
   PubMed Web of Science ®Google Scholar
• Kajdaniuk D, Marek B, Fołtyn W, Kos-Kudła B (2011)Vascular endothelial growth factor (VEGF) in endocrinology and oncology. Endokrynol. Pol. 3: 14–22.
   Google Scholar
• Kudugunti SK, Vad NM, Whiteside AJ, Naik BU, Yusuf MA, Srivenugopal KS, Moridani MY (2010)Biochemical mechanism of caffeic acid phenylethyl ester (CAPE) selective toxicity towards melanoma cell lines. Chem. Biol. Interact. 188: 1–14.
   PubMed Web of Science ®Google Scholar
• Lamour V, Nokin MJ, Henry A, Castronovo V, Bellahcène A (2013)Sibling proteins: molecular tools for tumor progression and angiogenesis. Med. Sci. 29: 1018–1025.
   Google Scholar
• Lazar D, Taban S, Raica M, Sporea I, Cornianu M, Goldış A, Vernıc C (2008)Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancer. Rom. J. Morphol. Embryol. 49: 137–148.
   PubMed Web of Science ®Google Scholar
• Lee KW, Kang NJ, Kim JH, Lee KM, Lee DE, Hur HJ, Lee HJ (2008)Caffeic acid phenethyl ester inhibits invasion and expression of matrix metalloproteinase in SK-Hep1 human hepatocellular carcinoma cells by targeting nuclear factor kappa B. Genes Nutr. 2: 319–322.
   PubMed Web of Science ®Google Scholar
• Li M, Liu F, Sun P, Gao Y, Chen H, Liu H, Wang M, Chen J, Zhao Y (2012)Correlations between serum levels of vascular endothelial growth factor and endostatin with clinical pathological characteristics of patients with gastrointestinal cancers. Hepato-Gastroenterology 59: 1865–1868.
   PubMed Web of Science ®Google Scholar
• Liao G,Wang Z, Zhao L, Zhang N, Dong P (2010)Inhibitory effects of cytoplasmic-domain substituted epidermal growth factor receptor on growth, invasion and angiogenesis in human gastric cancer cells. Molec. Med. Rep. 3: 287–294.
   PubMed Web of Science ®Google Scholar
• Liu L, Ma XL, Xiao ZL, Li M, Cheng SH, Wei YQ (2012)Prognostic value of vascular endothelial growth factor expression in resected gastric cancer. Asian Pac. J. Cancer Prev. 13: 3089–3097.
   PubMed Web of Science ®Google Scholar
• Loeffler S, Fayard B, Weis J, Weissenberger J (2005)Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int. J. Cancer 115: 202–213.
   PubMed Web of Science ®Google Scholar
• Muvaffak A, Gurhan I, Gunduz U, Hasirci N (2005)Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate. J. Drug Targ. 13: 151–159.
   PubMed Web of Science ®Google Scholar
• Nakao T, Kurita N, Komatsu M, Yoshikawa K, Iwata T, Utsunomiya T, Shimada M (2011)Expression of thrombospondin-1 and Ski are prognostic factors in advanced gastric cancer. Int. J. Clin. Oncol. 16: 145–152
   PubMed Web of Science ®Google Scholar
• Neschadim A, Summerlee AJ, Silvertown JD. (2014)Targeting the relaxin hormonal pathway in prostate cancer. Int. J. Cancer, doi: 10.1002/ijc.29079.
   PubMed Web of Science ®Google Scholar
• Onori P, DeMorrow S, Gaudio E, Franchitto A, Mancinelli R, Venter J, Kopriva S, Ueno Y, Alvaro D, Savage J, Alpini G, Francis H (2009)Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappa B and induction of apoptosis. Int. J. Cancer 125: 565–576.
   PubMed Web of Science ®Google Scholar
• Ribatti D, Guidolin D, Marzullo A, Nico B, Annese T, Benagiano V, Crivellato (2010)Mast cells and angiogenesis in gastric carcinoma. Int. J. Exp. Pathol. 91: 350–356.
   PubMed Web of Science ®Google Scholar
• Ribeiro U, Safatle-Ribeiro AV (2007)Caffeic acid phenethyl ester (CAPE) may be a promising adjuvant treatment in gastric cancer. Clin. Gastroenterol. 10: 871–873.
   Google Scholar
• Ryu KH, Shim KN, Jung SA, Yoo K, Joo YH, Lee JH (2012)Significance of preoperative tissue levels of vascular-endothelial cadherin, liver-intestine cadherin and vascular endothelial growth factor in gastric cancer. Kor. J. Gastroenterol. 60: 229–241.
   PubMedGoogle Scholar
• Saraswati S, Kanaujia PK, Kumar S, Kumar R, Alhaider AA (2013)Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis. Mol. Cancer 12: 82.
   PubMed Web of Science ®Google Scholar
• Sawada J, Li F, Komatsu M (2015)R-Ras protein inhibits autophosphorylation of vascular endothelial growth factor receptor 2 in endothelial cells and suppresses receptor activation in tumor vasculature. J. Biol. Chem. 290: 8133–8145.
   PubMed Web of Science ®Google Scholar
• Shimanuki Y, Takahashi K, Cui R, Hori S, Takahashi F, Miyamoto H, Fukurchi Y (2005)Role of serum vascular endothelial growth factor in the prediction of angiogenesis aud prognosis for non-small cell lung cancer. Lung 183: 29–42.
   PubMed Web of Science ®Google Scholar
• Shin EK, Kim JK (2012)Indirubin derivative E804 inhibits angiogenesis. BMC Cancer 12: 164.
   PubMed Web of Science ®Google Scholar
• Sodek LK, Brown TJ, Ringuette JM (2008)Collagen I, but not matrigel matrices, provide an MMP-dependent barrier to ovarian cancer cell penetration. BMC Cancer 8: 223.
   PubMed Web of Science ®Google Scholar
• Sun C, Li HL, Chen HR, Shi ML, Liu QH, Pan ZQ, Bai J, Zheng JN (2015)Decreased expression of CHIP leads to increased angiogenesis via VEGF-VEGFR2 pathway and poor prognosis in human renal cell carcinoma. Sci. Rep. 29: 9774.
   Web of Science ®Google Scholar
• Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN, Hsieh CY (2003)Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22: 1517–1527.
   PubMed Web of Science ®Google Scholar
• Wu CS, Chen MF, Lee IL, Tung SY (2007)Predictive role of nuclear factor-kappa B activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester. J. Clin. Gastroenterol. 41: 894–900.
   PubMed Web of Science ®Google Scholar
• Wu J, Omene C, Karkoszka J, Bosland M, Eckard J, Klein CB, Frenkel K (2011)Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer. Cancer Lett. 308: 43–53.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang L, Lin HK, Kan PY, Xie S, Tsai MY, Wang PH, Chen YT, Chang C (2003)Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells. Biochem. Biophys. Res. Commun. 305: 462–469.
   PubMed Web of Science ®Google Scholar
• Yu D, Chen J, Sun X, Zhuang L, Jiang C, Ding Y (2010)Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma. BMC Cancer 10: 435.
   PubMed Web of Science ®Google Scholar
• Yu Y, Cai W, Pei CG, Shao Y (2015)Rhamnazin, a novel inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy. Biochem. Biophys. Res. Commun. 458: 913–919.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ito R, Oue N, Zhu X, Kitadai Y, Yoshida K, Nakayama H, Yasui W (2003)Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma. Virchows Arch. 442: 563–568.
   PubMed Web of Science ®Google Scholar
• Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, Tsuneyama K, Takano Y (2006)Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res. 26: 3579–3584.
   PubMed Web of Science ®Google Scholar
• Zhou J, Bai C, Wang Y, Li X, Cheng Y, Chen S (2011)Endostatin combined with chemotherapy for treatment of metastatic colorectal and gastric cancer: a pilot study. Chin. Med. J. 124: 4299–4203.
   PubMed Web of Science ®Google Scholar
• Zhu BH, Chen HY, Zhan WH, Wang CY, Cai SR, Wang Z, Zhang CH, He YL (2011)(-)-Epigallocatechin- 3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer. World J. Gastroenterol. 17: 2315–2325.
   PubMed Web of Science ®Google Scholar